Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, has announced its participation in two major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference on September 3 at 10:20 a.m. ET and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9 at 3:20 p.m. ET.
Both presentations will be accessible via live audio webcast through the investor relations section of Amicus Therapeutics' corporate website. The company continues its commitment to developing first- and best-in-class medicines for rare diseases.
Amicus Therapeutics (Nasdaq: FOLD), azienda biotecnologica globale specializzata nelle malattie rare, ha annunciato la sua partecipazione a due importanti conferenze per investitori del settore sanitario a settembre 2025. La società terrà una presentazione al Cantor Global Healthcare Conference il 3 settembre alle 10:20 ET e al Morgan Stanley 23rd Annual Global Healthcare Conference il 9 settembre alle 15:20 ET.
Entrambe le presentazioni saranno fruibili tramite webcast audio in diretta nella sezione investor relations del sito corporate di Amicus Therapeutics. L'azienda conferma il proprio impegno nello sviluppo di terapie di prima e massima qualità per le malattie rare.
Amicus Therapeutics (Nasdaq: FOLD), una compañía biotecnológica global centrada en enfermedades raras, ha anunciado su participación en dos importantes conferencias para inversores del sector sanitario en septiembre de 2025. La empresa realizará una presentación en el Cantor Global Healthcare Conference el 3 de septiembre a las 10:20 ET y en el Morgan Stanley 23rd Annual Global Healthcare Conference el 9 de septiembre a las 15:20 ET.
Ambas presentaciones estarán disponibles mediante webcast de audio en directo a través de la sección de relaciones con inversores en la web corporativa de Amicus Therapeutics. La compañía reafirma su compromiso con el desarrollo de medicamentos de primera y mejor clase para las enfermedades raras.
Amicus Therapeutics (Nasdaq: FOLD), 희귀질환에 집중하는 글로벌 생명공학 기업이 2025년 9월 개최되는 주요 투자자 대상 헬스케어 컨퍼런스 두 곳에 참가한다고 발표했습니다. 회사는 Cantor Global Healthcare Conference에서 9월 3일 오전 10시 20분(ET)에, Morgan Stanley 23rd Annual Global Healthcare Conference에서 9월 9일 오후 3시 20분(ET)에 발표할 예정입니다.
두 발표 모두 Amicus Therapeutics 기업 웹사이트의 투자자 관계 섹션을 통해 라이브 오디오 웹캐스트로 시청할 수 있습니다. 회사는 희귀질환을 위한 최고 수준의 치료제 개발에 대한 의지를 계속 유지하고 있습니다.
Amicus Therapeutics (Nasdaq: FOLD), société biotechnologique mondiale spécialisée dans les maladies rares, a annoncé sa participation à deux grandes conférences pour investisseurs en santé en septembre 2025. Elle présentera au Cantor Global Healthcare Conference le 3 septembre à 10h20 ET et au Morgan Stanley 23rd Annual Global Healthcare Conference le 9 septembre à 15h20 ET.
Les deux présentations seront accessibles via webcast audio en direct depuis la rubrique relations investisseurs du site corporate d'Amicus Therapeutics. L'entreprise réaffirme son engagement à développer des médicaments de premier plan pour les maladies rares.
Amicus Therapeutics (Nasdaq: FOLD), ein globales Biotechnologieunternehmen mit Fokus auf seltene Erkrankungen, hat seine Teilnahme an zwei bedeutenden Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am Cantor Global Healthcare Conference am 3. September um 10:20 Uhr ET und am Morgan Stanley 23rd Annual Global Healthcare Conference am 9. September um 15:20 Uhr ET präsentieren.
Beide Präsentationen sind per Live-Audio-Webcast über den Investor-Relations-Bereich der Unternehmenswebseite von Amicus Therapeutics zugänglich. Das Unternehmen bekräftigt sein Engagement zur Entwicklung erstklassiger Therapien für seltene Erkrankungen.
- None.
- None.
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September.
- Cantor Global Healthcare Conference 2025 in New York, NY, on Wednesday, September 3, 2025, at 10:20 a.m. ET
- Morgan Stanley 23rd Annual Global Healthcare Conference 2025 in New York, NY on Tuesday, September 9, 2025, at 3:20 p.m. ET
A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Vice President, Corporate Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When is Amicus Therapeutics (FOLD) presenting at the Cantor Global Healthcare Conference 2025?
What time is FOLD's presentation at the Morgan Stanley Healthcare Conference 2025?
How can investors access Amicus Therapeutics' conference presentations in September 2025?
What is Amicus Therapeutics' (FOLD) main business focus?
